CD44+ fibroblasts increases breast cancer cell survival and drug resistance via IGF2BP3-CD44-IGF2 signalling-Reference-Cited by-同舟云学术

CD44+ fibroblasts increases breast cancer cell survival and drug resistance via IGF2BP3-CD44-IGF2 signalling

Author:

Liu Yonglei¹²³⁴,Yu Conghui⁵,Wu Yonggang⁶,Sun Xiangjun⁷,Su Quanping¹,You Cuiping¹,Xin Hongwu³⁴

Affiliation:

1. Research Center; Linyi People's Hospital; Shandong China

2. Zhongshan Hospital; Fudan University; Shanghai China

3. The First Peoples' Hospital; School of Clinical Medicine; Yangtze University; Jingzhou Hubei China

4. Laboratory of Oncology; Center for Molecular Medicine; School of Medicine; Yangtze University; Jingzhou Hubei China

5. Department of Hepatobilinary Surgery; The General Hospital of Beijing Military Region of China; Beijing China

6. Department of Orthopedics; Bayannaoer City Hospital; Bayannaoer City Inner Mongolia China

7. Department of Surgery; Linyi People's Hospital; Shandong China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

Reference20 articles.

3. Role of carcinoma-associated fibroblasts and hypoxia in tumor progression;Giaccia;Curr Top Microbiol Immunol,2010

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献